| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cell quiescence | 2.60e-08 | 8 | 17 | 3 | GO:0044838 | |
| GeneOntologyBiologicalProcess | glial cell fate specification | 3.89e-08 | 9 | 17 | 3 | GO:0021780 | |
| GeneOntologyBiologicalProcess | glial cell fate commitment | 4.47e-07 | 19 | 17 | 3 | GO:0021781 | |
| GeneOntologyBiologicalProcess | cell cycle phase | 1.34e-06 | 27 | 17 | 3 | GO:0022403 | |
| GeneOntologyBiologicalProcess | exit from mitosis | 3.55e-06 | 37 | 17 | 3 | GO:0010458 | |
| GeneOntologyBiologicalProcess | neuron fate specification | 5.23e-06 | 42 | 17 | 3 | GO:0048665 | |
| GeneOntologyBiologicalProcess | biological phase | 1.06e-05 | 53 | 17 | 3 | GO:0044848 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 3.60e-05 | 237 | 17 | 4 | GO:0019827 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 3.90e-05 | 242 | 17 | 4 | GO:0098727 | |
| GeneOntologyBiologicalProcess | glial cell proliferation | 4.72e-05 | 87 | 17 | 3 | GO:0014009 | |
| GeneOntologyBiologicalProcess | neuron fate commitment | 5.40e-05 | 91 | 17 | 3 | GO:0048663 | |
| GeneOntologyBiologicalProcess | negative regulation of acute inflammatory response | 9.71e-05 | 18 | 17 | 2 | GO:0002674 | |
| GeneOntologyBiologicalProcess | DNA replication | 1.05e-04 | 312 | 17 | 4 | GO:0006260 | |
| GeneOntologyBiologicalProcess | cell fate specification | 1.32e-04 | 123 | 17 | 3 | GO:0001708 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 1.36e-04 | 334 | 17 | 4 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 1.36e-04 | 334 | 17 | 4 | GO:0001894 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | 1.53e-04 | 1081 | 17 | 6 | GO:0006259 | |
| GeneOntologyBiologicalProcess | cell proliferation in forebrain | 4.42e-04 | 38 | 17 | 2 | GO:0021846 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 6.01e-04 | 1390 | 17 | 6 | GO:0045944 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 6.22e-04 | 1399 | 17 | 6 | GO:0045892 | |
| GeneOntologyBiologicalProcess | retina development in camera-type eye | 6.46e-04 | 211 | 17 | 3 | GO:0060041 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 6.56e-04 | 1413 | 17 | 6 | GO:1902679 | |
| GeneOntologyBiologicalProcess | nuclear division | 6.91e-04 | 512 | 17 | 4 | GO:0000280 | |
| GeneOntologyBiologicalProcess | homeostasis of number of cells within a tissue | 7.96e-04 | 51 | 17 | 2 | GO:0048873 | |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 8.61e-04 | 233 | 17 | 3 | GO:0061351 | |
| GeneOntologyBiologicalProcess | macrophage cytokine production | 9.25e-04 | 55 | 17 | 2 | GO:0010934 | |
| GeneOntologyBiologicalProcess | organelle fission | 1.04e-03 | 571 | 17 | 4 | GO:0048285 | |
| GeneOntologyBiologicalProcess | positive regulation of alpha-beta T cell differentiation | 1.25e-03 | 64 | 17 | 2 | GO:0046638 | |
| GeneOntologyBiologicalProcess | skeletal system development | 1.37e-03 | 615 | 17 | 4 | GO:0001501 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response | 1.37e-03 | 67 | 17 | 2 | GO:0002673 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte cytokine production | 1.58e-03 | 72 | 17 | 2 | GO:0061082 | |
| GeneOntologyBiologicalProcess | mitotic nuclear division | 2.07e-03 | 316 | 17 | 3 | GO:0140014 | |
| GeneOntologyBiologicalProcess | regulation of miRNA transcription | 2.09e-03 | 83 | 17 | 2 | GO:1902893 | |
| GeneOntologyBiologicalProcess | miRNA transcription | 2.14e-03 | 84 | 17 | 2 | GO:0061614 | |
| GeneOntologyBiologicalProcess | glial cell differentiation | 2.16e-03 | 321 | 17 | 3 | GO:0010001 | |
| GeneOntologyBiologicalProcess | positive regulation of alpha-beta T cell activation | 2.40e-03 | 89 | 17 | 2 | GO:0046635 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 2.50e-03 | 338 | 17 | 3 | GO:0045165 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell differentiation | 2.62e-03 | 93 | 17 | 2 | GO:0046637 | |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 3.20e-03 | 103 | 17 | 2 | GO:2000628 | |
| MousePheno | decreased trabecular bone mass | 1.27e-04 | 20 | 12 | 2 | MP:0010873 | |
| MousePheno | abnormal corpus callosum morphology | 1.59e-04 | 129 | 12 | 3 | MP:0000780 | |
| MousePheno | abnormal dorsal telencephalic commissure morphology | 1.70e-04 | 132 | 12 | 3 | MP:0008219 | |
| MousePheno | abnormal hippocampal commissure morphology | 2.52e-04 | 28 | 12 | 2 | MP:0008221 | |
| MousePheno | abnormal brain commissure morphology | 3.06e-04 | 161 | 12 | 3 | MP:0002199 | |
| MousePheno | absent corpus callosum | 3.51e-04 | 33 | 12 | 2 | MP:0002196 | |
| MousePheno | dilated third ventricle | 3.73e-04 | 34 | 12 | 2 | MP:0000827 | |
| MousePheno | abnormal nervous system tract morphology | 4.89e-04 | 189 | 12 | 3 | MP:0000778 | |
| MousePheno | abnormal brain white matter morphology | 6.29e-04 | 206 | 12 | 3 | MP:0008026 | |
| MousePheno | abnormal cerebellar granule cell morphology | 6.55e-04 | 45 | 12 | 2 | MP:0004098 | |
| MousePheno | abnormal trabecular bone mass | 6.55e-04 | 45 | 12 | 2 | MP:0010871 | |
| MousePheno | abnormal hippocampus region morphology | 8.41e-04 | 51 | 12 | 2 | MP:0008262 | |
| MousePheno | abnormal eyelid morphology | 9.00e-04 | 233 | 12 | 3 | MP:0001340 | |
| MousePheno | abnormal Ammon gyrus morphology | 9.78e-04 | 55 | 12 | 2 | MP:0000815 | |
| MousePheno | decreased trabecular bone thickness | 1.05e-03 | 57 | 12 | 2 | MP:0009346 | |
| MousePheno | abnormal cerebellar foliation | 1.09e-03 | 58 | 12 | 2 | MP:0000857 | |
| MousePheno | dilated lateral ventricle | 1.41e-03 | 66 | 12 | 2 | MP:0000825 | |
| MousePheno | abnormal cerebellum lobule morphology | 1.53e-03 | 69 | 12 | 2 | MP:0009964 | |
| MousePheno | abnormal brain ventricle morphology | 1.63e-03 | 286 | 12 | 3 | MP:0000822 | |
| MousePheno | abnormal third ventricle morphology | 1.96e-03 | 78 | 12 | 2 | MP:0000826 | |
| MousePheno | decreased compact bone thickness | 2.21e-03 | 83 | 12 | 2 | MP:0000135 | |
| MousePheno | increased circulating tumor necrosis factor level | 2.32e-03 | 85 | 12 | 2 | MP:0008553 | |
| MousePheno | abnormal cerebellar granule layer morphology | 2.32e-03 | 85 | 12 | 2 | MP:0000886 | |
| MousePheno | abnormal dentate gyrus morphology | 2.37e-03 | 86 | 12 | 2 | MP:0000812 | |
| MousePheno | abnormal hippocampus morphology | 2.47e-03 | 331 | 12 | 3 | MP:0000807 | |
| MousePheno | abnormal temporal lobe morphology | 2.60e-03 | 337 | 12 | 3 | MP:0000801 | |
| MousePheno | dilated brain ventricle | 2.71e-03 | 92 | 12 | 2 | MP:0012676 | |
| Domain | CTF/NFI | 2.69e-13 | 4 | 15 | 4 | IPR000647 | |
| Domain | CTF/NFI_DNA-bd_N | 2.69e-13 | 4 | 15 | 4 | IPR019548 | |
| Domain | NfI_DNAbd_pre-N | 2.69e-13 | 4 | 15 | 4 | PF10524 | |
| Domain | CTF_NFI | 2.69e-13 | 4 | 15 | 4 | PF00859 | |
| Domain | CTF_NFI_2 | 2.69e-13 | 4 | 15 | 4 | PS51080 | |
| Domain | CTF/NFI_DNA-bd_CS | 2.69e-13 | 4 | 15 | 4 | IPR019739 | |
| Domain | CTF_NFI_1 | 2.69e-13 | 4 | 15 | 4 | PS00349 | |
| Domain | CTF/NFI_DNA-bd-dom | 2.69e-13 | 4 | 15 | 4 | IPR020604 | |
| Domain | MH1 | 1.33e-10 | 12 | 15 | 4 | PF03165 | |
| Domain | MAD_homology1_Dwarfin-type | 1.33e-10 | 12 | 15 | 4 | IPR003619 | |
| Domain | DWA | 1.33e-10 | 12 | 15 | 4 | SM00523 | |
| Domain | ssDNA-bd_transcriptional_reg | 1.81e-06 | 3 | 15 | 2 | IPR009044 | |
| Domain | - | 2.11e-02 | 283 | 15 | 2 | 1.10.10.60 | |
| Pathway | REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION | 7.26e-09 | 23 | 15 | 4 | M1024 | |
| Pathway | REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION | 8.21e-08 | 41 | 15 | 4 | M739 | |
| Pathway | PID_HNF3A_PATHWAY | 1.26e-05 | 44 | 15 | 3 | M285 | |
| Pubmed | Transcription factor NF 1 expression in involuting mammary gland. | 3.90e-14 | 4 | 17 | 4 | 10959417 | |
| Pubmed | 3.90e-14 | 4 | 17 | 4 | 7590749 | ||
| Pubmed | Nuclear factor one transcription factors as epigenetic regulators in cancer. | 3.90e-14 | 4 | 17 | 4 | 28076901 | |
| Pubmed | 3.90e-14 | 4 | 17 | 4 | 9052991 | ||
| Pubmed | 3.90e-14 | 4 | 17 | 4 | 9056636 | ||
| Pubmed | 3.90e-14 | 4 | 17 | 4 | 12568726 | ||
| Pubmed | 1.95e-13 | 5 | 17 | 4 | 19706729 | ||
| Pubmed | 5.85e-13 | 6 | 17 | 4 | 21270437 | ||
| Pubmed | 1.37e-12 | 7 | 17 | 4 | 10762365 | ||
| Pubmed | TGF-β/NF1/Smad4-mediated suppression of ANT2 contributes to oxidative stress in cellular senescence. | 1.37e-12 | 7 | 17 | 4 | 25220407 | |
| Pubmed | Nfix regulates fetal-specific transcription in developing skeletal muscle. | 1.29e-11 | 11 | 17 | 4 | 20178747 | |
| Pubmed | 2.78e-11 | 13 | 17 | 4 | 17553984 | ||
| Pubmed | Exon structure of the nuclear factor I DNA-binding domain from C. elegans to mammals. | 7.08e-11 | 16 | 17 | 4 | 10087299 | |
| Pubmed | 9.70e-11 | 3 | 17 | 3 | 31128945 | ||
| Pubmed | 9.70e-11 | 3 | 17 | 3 | 9099724 | ||
| Pubmed | 3.88e-10 | 4 | 17 | 3 | 28295292 | ||
| Pubmed | Gene regulatory networks controlling vertebrate retinal regeneration. | 3.88e-10 | 4 | 17 | 3 | 33004674 | |
| Pubmed | RFX1 and NF-1 associate with P sequences of the human growth hormone locus in pituitary chromatin. | 3.88e-10 | 4 | 17 | 3 | 12624117 | |
| Pubmed | Control of neurogenic competence in mammalian hypothalamic tanycytes. | 9.69e-10 | 5 | 17 | 3 | 34049878 | |
| Pubmed | The transcription factor gene Nfib is essential for both lung maturation and brain development. | 1.06e-09 | 30 | 17 | 4 | 15632069 | |
| Pubmed | 1.94e-09 | 6 | 17 | 3 | 19107796 | ||
| Pubmed | 5.42e-09 | 8 | 17 | 3 | 25960350 | ||
| Pubmed | 2.77e-08 | 13 | 17 | 3 | 29106906 | ||
| Pubmed | 2.22e-07 | 25 | 17 | 3 | 18324732 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 29577671 | ||
| Pubmed | Nuclear Factor IA Is Down-regulated in Muscle-invasive and High-grade Bladder Cancers. | 2.25e-07 | 2 | 17 | 2 | 34969759 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 38366751 | ||
| Pubmed | Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma. | 2.25e-07 | 2 | 17 | 2 | 31760595 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 32068188 | ||
| Pubmed | Transcriptional diversity during lineage commitment of human blood progenitors. | 2.25e-07 | 2 | 17 | 2 | 25258084 | |
| Pubmed | 3.91e-07 | 30 | 17 | 3 | 23042737 | ||
| Pubmed | 5.24e-07 | 33 | 17 | 3 | 26071364 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 12955085 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 10085123 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 38267731 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 18809517 | ||
| Pubmed | PAX6 does not regulate Nfia and Nfib expression during neocortical development. | 6.74e-07 | 3 | 17 | 2 | 26021864 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 32393888 | ||
| Pubmed | NFIA and GATA3 are crucial regulators of embryonic articular cartilage differentiation. | 1.35e-06 | 4 | 17 | 2 | 29247144 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 20431063 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 19540848 | ||
| Pubmed | Transcriptional analysis of Gli3 mutants identifies Wnt target genes in the developing hippocampus. | 1.55e-06 | 47 | 17 | 3 | 22235033 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.57e-06 | 180 | 17 | 4 | 35198878 | |
| Pubmed | Nuclear factor I gene expression in the developing forebrain. | 2.25e-06 | 5 | 17 | 2 | 18335562 | |
| Pubmed | Expression of nuclear factor one A and -B in the olfactory bulb. | 2.25e-06 | 5 | 17 | 2 | 22886731 | |
| Pubmed | MicroRNA-153 Regulates the Acquisition of Gliogenic Competence by Neural Stem Cells. | 2.25e-06 | 5 | 17 | 2 | 26212661 | |
| Pubmed | The transcription factor NFIA controls the onset of gliogenesis in the developing spinal cord. | 3.37e-06 | 6 | 17 | 2 | 17178400 | |
| Pubmed | NFIA and NFIB function as tumour suppressors in high-grade glioma in mice. | 3.37e-06 | 6 | 17 | 2 | 33346791 | |
| Pubmed | Combined allelic dosage of Nfia and Nfib regulates cortical development. | 4.72e-06 | 7 | 17 | 2 | 32166136 | |
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 19429788 | ||
| Pubmed | 7.58e-06 | 268 | 17 | 4 | 33640491 | ||
| Pubmed | 8.08e-06 | 9 | 17 | 2 | 27965439 | ||
| Pubmed | 8.70e-06 | 83 | 17 | 3 | 28794006 | ||
| Pubmed | 1.01e-05 | 10 | 17 | 2 | 11978849 | ||
| Pubmed | 1.23e-05 | 11 | 17 | 2 | 22925353 | ||
| Pubmed | Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. | 1.23e-05 | 11 | 17 | 2 | 19416921 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 1.54e-05 | 321 | 17 | 4 | 32098917 | |
| Pubmed | 1.62e-05 | 102 | 17 | 3 | 19741146 | ||
| Pubmed | Ikaros family proteins redundantly regulate temporal patterning in the developing mouse retina. | 2.04e-05 | 14 | 17 | 2 | 36537580 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 2.28e-05 | 1294 | 17 | 6 | 30804502 | |
| Pubmed | 2.35e-05 | 15 | 17 | 2 | 19961580 | ||
| Pubmed | 2.69e-05 | 16 | 17 | 2 | 27732850 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.83e-05 | 123 | 17 | 3 | 26912792 | |
| Pubmed | 3.05e-05 | 17 | 17 | 2 | 23749646 | ||
| Pubmed | Genetic analysis of anterior posterior expression gradients in the developing mammalian forebrain. | 3.42e-05 | 18 | 17 | 2 | 17150988 | |
| Pubmed | 4.70e-05 | 21 | 17 | 2 | 33871356 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 5.02e-05 | 1489 | 17 | 6 | 28611215 | |
| Pubmed | 5.43e-05 | 153 | 17 | 3 | 10718198 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 5.72e-05 | 908 | 17 | 5 | 19274049 | |
| Pubmed | Transcriptional dynamics of murine motor neuron maturation in vivo and in vitro. | 6.17e-05 | 24 | 17 | 2 | 36109497 | |
| Pubmed | Dentate gyrus morphogenesis is regulated by β-catenin function in hem-derived fimbrial glia. | 6.70e-05 | 25 | 17 | 2 | 36196585 | |
| Pubmed | Semaphorin heterodimerization in cis regulates membrane targeting and neocortical wiring. | 7.26e-05 | 26 | 17 | 2 | 39152101 | |
| Pubmed | Transcriptional Architecture of Synaptic Communication Delineates GABAergic Neuron Identity. | 1.04e-04 | 31 | 17 | 2 | 28942923 | |
| Pubmed | 1.11e-04 | 32 | 17 | 2 | 20610746 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 1.56e-04 | 583 | 17 | 4 | 29844126 | |
| Pubmed | Transcriptional network orchestrating regional patterning of cortical progenitors. | 1.65e-04 | 39 | 17 | 2 | 34921112 | |
| Pubmed | Wnt/β-catenin signaling regulates sequential fate decisions of murine cortical precursor cells. | 2.30e-04 | 46 | 17 | 2 | 25182747 | |
| Pubmed | 2.40e-04 | 47 | 17 | 2 | 35462405 | ||
| Pubmed | 2.51e-04 | 257 | 17 | 3 | 30945288 | ||
| Pubmed | A cascade of morphogenic signaling initiated by the meninges controls corpus callosum formation. | 2.72e-04 | 50 | 17 | 2 | 22365545 | |
| Pubmed | 3.00e-04 | 1293 | 17 | 5 | 15342556 | ||
| Pubmed | 3.41e-04 | 56 | 17 | 2 | 34170322 | ||
| Pubmed | 4.76e-04 | 1429 | 17 | 5 | 35140242 | ||
| Interaction | SOX15 interactions | 9.03e-08 | 141 | 17 | 5 | int:SOX15 | |
| Interaction | TLX2 interactions | 9.35e-08 | 142 | 17 | 5 | int:TLX2 | |
| Interaction | NUP43 interactions | 3.96e-07 | 625 | 17 | 7 | int:NUP43 | |
| Interaction | NR2C1 interactions | 6.41e-07 | 84 | 17 | 4 | int:NR2C1 | |
| Interaction | PAX2 interactions | 6.73e-07 | 85 | 17 | 4 | int:PAX2 | |
| Interaction | PRR12 interactions | 7.73e-07 | 88 | 17 | 4 | int:PRR12 | |
| Interaction | SOX10 interactions | 9.25e-07 | 92 | 17 | 4 | int:SOX10 | |
| Interaction | ZNF608 interactions | 9.66e-07 | 93 | 17 | 4 | int:ZNF608 | |
| Interaction | SOX17 interactions | 1.05e-06 | 95 | 17 | 4 | int:SOX17 | |
| Interaction | ETV7 interactions | 1.44e-06 | 27 | 17 | 3 | int:ETV7 | |
| Interaction | MIDEAS interactions | 1.76e-06 | 108 | 17 | 4 | int:MIDEAS | |
| Interaction | PAX8 interactions | 1.96e-06 | 111 | 17 | 4 | int:PAX8 | |
| Interaction | TBR1 interactions | 2.11e-06 | 113 | 17 | 4 | int:TBR1 | |
| Interaction | ARID3B interactions | 2.11e-06 | 113 | 17 | 4 | int:ARID3B | |
| Interaction | BCL7C interactions | 2.26e-06 | 115 | 17 | 4 | int:BCL7C | |
| Interaction | ARID3A interactions | 2.86e-06 | 122 | 17 | 4 | int:ARID3A | |
| Interaction | PAX7 interactions | 3.05e-06 | 124 | 17 | 4 | int:PAX7 | |
| Interaction | PAX9 interactions | 3.69e-06 | 130 | 17 | 4 | int:PAX9 | |
| Interaction | TBL1X interactions | 4.67e-06 | 138 | 17 | 4 | int:TBL1X | |
| Interaction | NFIB interactions | 5.24e-06 | 142 | 17 | 4 | int:NFIB | |
| Interaction | TRPS1 interactions | 5.38e-06 | 143 | 17 | 4 | int:TRPS1 | |
| Interaction | ZNF148 interactions | 5.54e-06 | 144 | 17 | 4 | int:ZNF148 | |
| Interaction | ZNF609 interactions | 5.85e-06 | 146 | 17 | 4 | int:ZNF609 | |
| Interaction | ATXN1L interactions | 6.51e-06 | 150 | 17 | 4 | int:ATXN1L | |
| Interaction | GSE1 interactions | 7.22e-06 | 154 | 17 | 4 | int:GSE1 | |
| Interaction | SIX4 interactions | 7.40e-06 | 46 | 17 | 3 | int:SIX4 | |
| Interaction | SOX6 interactions | 7.80e-06 | 157 | 17 | 4 | int:SOX6 | |
| Interaction | SATB2 interactions | 8.20e-06 | 159 | 17 | 4 | int:SATB2 | |
| Interaction | KDM2B interactions | 8.61e-06 | 161 | 17 | 4 | int:KDM2B | |
| Interaction | SOX5 interactions | 8.83e-06 | 162 | 17 | 4 | int:SOX5 | |
| Interaction | KDM6A interactions | 8.83e-06 | 162 | 17 | 4 | int:KDM6A | |
| Interaction | LHX4 interactions | 9.72e-06 | 166 | 17 | 4 | int:LHX4 | |
| Interaction | KMT2D interactions | 1.04e-05 | 169 | 17 | 4 | int:KMT2D | |
| Interaction | ARID1B interactions | 1.25e-05 | 177 | 17 | 4 | int:ARID1B | |
| Interaction | SMARCD2 interactions | 1.43e-05 | 183 | 17 | 4 | int:SMARCD2 | |
| Interaction | HIVEP1 interactions | 1.52e-05 | 186 | 17 | 4 | int:HIVEP1 | |
| Interaction | ZNF644 interactions | 1.52e-05 | 186 | 17 | 4 | int:ZNF644 | |
| Interaction | EHMT1 interactions | 1.59e-05 | 188 | 17 | 4 | int:EHMT1 | |
| Interaction | NFIA interactions | 1.59e-05 | 188 | 17 | 4 | int:NFIA | |
| Interaction | ZNF281 interactions | 1.91e-05 | 197 | 17 | 4 | int:ZNF281 | |
| Interaction | RLF interactions | 2.21e-05 | 66 | 17 | 3 | int:RLF | |
| Interaction | NFIC interactions | 2.45e-05 | 210 | 17 | 4 | int:NFIC | |
| Interaction | TLE1 interactions | 2.59e-05 | 213 | 17 | 4 | int:TLE1 | |
| Interaction | NFIX interactions | 3.33e-05 | 227 | 17 | 4 | int:NFIX | |
| Interaction | FOXC1 interactions | 3.38e-05 | 228 | 17 | 4 | int:FOXC1 | |
| Interaction | RFX1 interactions | 4.08e-05 | 81 | 17 | 3 | int:RFX1 | |
| Interaction | PRDM1 interactions | 4.55e-05 | 84 | 17 | 3 | int:PRDM1 | |
| Interaction | FOXP1 interactions | 5.31e-05 | 256 | 17 | 4 | int:FOXP1 | |
| Interaction | FOXA1 interactions | 5.62e-05 | 525 | 17 | 5 | int:FOXA1 | |
| Interaction | NCOR2 interactions | 5.99e-05 | 264 | 17 | 4 | int:NCOR2 | |
| Interaction | DPF1 interactions | 6.58e-05 | 95 | 17 | 3 | int:DPF1 | |
| Interaction | SOX9 interactions | 7.00e-05 | 97 | 17 | 3 | int:SOX9 | |
| Interaction | ARID1A interactions | 7.12e-05 | 276 | 17 | 4 | int:ARID1A | |
| Interaction | FOXP4 interactions | 7.22e-05 | 98 | 17 | 3 | int:FOXP4 | |
| Interaction | TLX3 interactions | 8.74e-05 | 291 | 17 | 4 | int:TLX3 | |
| Interaction | BCOR interactions | 1.01e-04 | 302 | 17 | 4 | int:BCOR | |
| Interaction | IRF2BP2 interactions | 1.02e-04 | 110 | 17 | 3 | int:IRF2BP2 | |
| Interaction | SP7 interactions | 1.03e-04 | 304 | 17 | 4 | int:SP7 | |
| Interaction | FOS interactions | 1.14e-04 | 312 | 17 | 4 | int:FOS | |
| Interaction | TBXT interactions | 1.19e-04 | 116 | 17 | 3 | int:TBXT | |
| Interaction | ELK3 interactions | 1.32e-04 | 120 | 17 | 3 | int:ELK3 | |
| Interaction | SNRNP40 interactions | 1.40e-04 | 637 | 17 | 5 | int:SNRNP40 | |
| Interaction | ATXN1 interactions | 1.40e-04 | 1039 | 17 | 6 | int:ATXN1 | |
| Interaction | DTX2 interactions | 1.42e-04 | 330 | 17 | 4 | int:DTX2 | |
| Interaction | SMARCA2 interactions | 1.70e-04 | 346 | 17 | 4 | int:SMARCA2 | |
| Interaction | DPF2 interactions | 1.76e-04 | 349 | 17 | 4 | int:DPF2 | |
| Interaction | SMARCD1 interactions | 1.76e-04 | 349 | 17 | 4 | int:SMARCD1 | |
| Interaction | PAXIP1 interactions | 1.96e-04 | 359 | 17 | 4 | int:PAXIP1 | |
| Interaction | NCOR1 interactions | 2.05e-04 | 363 | 17 | 4 | int:NCOR1 | |
| Interaction | PAX6 interactions | 2.11e-04 | 366 | 17 | 4 | int:PAX6 | |
| Interaction | ZBTB7B interactions | 2.11e-04 | 366 | 17 | 4 | int:ZBTB7B | |
| Interaction | DDA1 interactions | 2.16e-04 | 368 | 17 | 4 | int:DDA1 | |
| Interaction | TLE3 interactions | 2.34e-04 | 376 | 17 | 4 | int:TLE3 | |
| Interaction | MNX1 interactions | 2.50e-04 | 28 | 17 | 2 | int:MNX1 | |
| Interaction | TFAP4 interactions | 2.70e-04 | 153 | 17 | 3 | int:TFAP4 | |
| Interaction | ELF2 interactions | 2.86e-04 | 156 | 17 | 3 | int:ELF2 | |
| Interaction | NOP2 interactions | 3.44e-04 | 416 | 17 | 4 | int:NOP2 | |
| Interaction | KLF16 interactions | 3.73e-04 | 425 | 17 | 4 | int:KLF16 | |
| Interaction | TLX1 interactions | 4.00e-04 | 175 | 17 | 3 | int:TLX1 | |
| Interaction | TEAD1 interactions | 4.07e-04 | 176 | 17 | 3 | int:TEAD1 | |
| Interaction | LHX2 interactions | 4.56e-04 | 183 | 17 | 3 | int:LHX2 | |
| Interaction | LHX3 interactions | 4.71e-04 | 185 | 17 | 3 | int:LHX3 | |
| Interaction | E2F6 interactions | 4.71e-04 | 185 | 17 | 3 | int:E2F6 | |
| Interaction | GATA3 interactions | 4.86e-04 | 187 | 17 | 3 | int:GATA3 | |
| Interaction | PARP1 interactions | 5.07e-04 | 1316 | 17 | 6 | int:PARP1 | |
| Interaction | KLF12 interactions | 5.41e-04 | 194 | 17 | 3 | int:KLF12 | |
| Interaction | FOXL1 interactions | 5.57e-04 | 196 | 17 | 3 | int:FOXL1 | |
| Interaction | GATA2 interactions | 5.82e-04 | 199 | 17 | 3 | int:GATA2 | |
| Interaction | ARID4B interactions | 5.82e-04 | 199 | 17 | 3 | int:ARID4B | |
| Interaction | FEV interactions | 6.17e-04 | 203 | 17 | 3 | int:FEV | |
| Interaction | DPY30 interactions | 6.26e-04 | 204 | 17 | 3 | int:DPY30 | |
| Interaction | PCGF1 interactions | 6.62e-04 | 208 | 17 | 3 | int:PCGF1 | |
| Interaction | WIZ interactions | 7.79e-04 | 220 | 17 | 3 | int:WIZ | |
| Interaction | ERG interactions | 8.11e-04 | 223 | 17 | 3 | int:ERG | |
| Interaction | NCOA3 interactions | 8.21e-04 | 224 | 17 | 3 | int:NCOA3 | |
| Interaction | RPS24 interactions | 8.51e-04 | 529 | 17 | 4 | int:RPS24 | |
| Interaction | KLF3 interactions | 8.64e-04 | 228 | 17 | 3 | int:KLF3 | |
| Interaction | HMG20A interactions | 1.05e-03 | 244 | 17 | 3 | int:HMG20A | |
| Interaction | AR interactions | 1.08e-03 | 992 | 17 | 5 | int:AR | |
| Interaction | NOP56 interactions | 1.12e-03 | 570 | 17 | 4 | int:NOP56 | |
| Cytoband | 19p13.3 | 3.43e-03 | 237 | 17 | 2 | 19p13.3 | |
| Coexpression | KAUFFMANN_DNA_REPLICATION_GENES | 2.08e-06 | 146 | 17 | 4 | M9372 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_2_EXCITATORY_NEURON | 4.73e-05 | 16 | 17 | 2 | M39025 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_STROMAL_CELL_AGEING | 6.41e-05 | 349 | 17 | 4 | MM3790 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 8.24e-05 | 133 | 17 | 3 | M8880 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 9.00e-05 | 137 | 17 | 3 | MM990 | |
| Coexpression | GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 1.83e-04 | 174 | 17 | 3 | M9007 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN | 2.51e-04 | 194 | 17 | 3 | M8864 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_UP | 2.71e-04 | 199 | 17 | 3 | MM991 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_UP | 2.71e-04 | 199 | 17 | 3 | M2155 | |
| Coexpression | GSE34006_WT_VS_A2AR_KO_TREG_UP | 2.75e-04 | 200 | 17 | 3 | M9047 | |
| Coexpression | GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_DN | 2.75e-04 | 200 | 17 | 3 | M8575 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 3.68e-04 | 221 | 17 | 3 | M39222 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.85e-06 | 123 | 16 | 4 | gudmap_developingGonad_e16.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.01e-06 | 139 | 16 | 4 | gudmap_developingGonad_e18.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.19e-06 | 141 | 16 | 4 | gudmap_developingGonad_P2_epididymis_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.15e-06 | 51 | 16 | 3 | gudmap_developingGonad_P2_testes_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.16e-06 | 184 | 16 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_500 | 1.42e-05 | 64 | 16 | 3 | gudmap_developingGonad_e18.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 1.59e-05 | 797 | 16 | 6 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.66e-05 | 214 | 16 | 4 | gudmap_developingGonad_e16.5_testes_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_500 | 4.10e-05 | 91 | 16 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.19e-05 | 271 | 16 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 5.06e-05 | 978 | 16 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | 5.20e-05 | 983 | 16 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.67e-05 | 293 | 16 | 4 | gudmap_developingGonad_e18.5_testes_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 6.06e-05 | 298 | 16 | 4 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_500 | 1.16e-04 | 129 | 16 | 3 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k4_500 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | 1.23e-04 | 1148 | 16 | 6 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 1.38e-04 | 137 | 16 | 3 | Facebase_RNAseq_e9.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.61e-04 | 384 | 16 | 4 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | 1.68e-04 | 388 | 16 | 4 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.83e-04 | 397 | 16 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_200 | 1.85e-04 | 27 | 16 | 2 | gudmap_developingGonad_e18.5_epididymis_200_k4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 1.96e-04 | 404 | 16 | 4 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 2.00e-04 | 406 | 16 | 4 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 2.06e-04 | 780 | 16 | 5 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_200 | 2.14e-04 | 29 | 16 | 2 | gudmap_developingGonad_e16.5_epididymis_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 2.18e-04 | 790 | 16 | 5 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_200 | 2.19e-04 | 160 | 16 | 3 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_200 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | 2.20e-04 | 791 | 16 | 5 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 2.30e-04 | 799 | 16 | 5 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 2.33e-04 | 801 | 16 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200 | 2.44e-04 | 166 | 16 | 3 | gudmap_developingGonad_e16.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200 | 2.44e-04 | 166 | 16 | 3 | gudmap_developingGonad_e18.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | 2.47e-04 | 811 | 16 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000 | 2.51e-04 | 814 | 16 | 5 | gudmap_developingGonad_e18.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000 | 2.58e-04 | 819 | 16 | 5 | gudmap_developingGonad_e16.5_testes_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.76e-04 | 831 | 16 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_200 | 2.77e-04 | 33 | 16 | 2 | gudmap_developingGonad_P2_epididymis_200_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.46e-04 | 187 | 16 | 3 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | 5.56e-04 | 967 | 16 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | 5.56e-04 | 967 | 16 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | 5.80e-04 | 976 | 16 | 5 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | 6.02e-04 | 984 | 16 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 6.49e-04 | 232 | 16 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.16e-04 | 240 | 16 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 7.69e-04 | 246 | 16 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-vs-F_top274_274 | 8.63e-04 | 256 | 16 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.54e-04 | 265 | 16 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#1 | 9.54e-04 | 265 | 16 | 3 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305 | 9.65e-04 | 266 | 16 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.01e-03 | 63 | 16 | 2 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_200 | 1.04e-03 | 64 | 16 | 2 | gudmap_developingGonad_e18.5_epididymis_200_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.07e-03 | 276 | 16 | 3 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.13e-03 | 642 | 16 | 4 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.19e-03 | 652 | 16 | 4 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.24e-03 | 290 | 16 | 3 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.25e-03 | 291 | 16 | 3 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_500 | 1.28e-03 | 71 | 16 | 2 | gudmap_developingGonad_P2_epididymis_500_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | 1.30e-03 | 1166 | 16 | 5 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_100 | 1.36e-03 | 73 | 16 | 2 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_100 | |
| CoexpressionAtlas | e10.5_Emin_MedialNasal_top-relative-expression-ranked_500 | 1.36e-03 | 300 | 16 | 3 | Facebase_ST1_e10.5_Emin_MedialNasal_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.43e-03 | 305 | 16 | 3 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_200 | 1.43e-03 | 75 | 16 | 2 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.51e-03 | 311 | 16 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.58e-03 | 316 | 16 | 3 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.78e-03 | 726 | 16 | 4 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.79e-03 | 330 | 16 | 3 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.82e-03 | 731 | 16 | 4 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.85e-03 | 734 | 16 | 4 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_1000 | 1.85e-03 | 734 | 16 | 4 | gudmap_developingLowerUrinaryTract_adult_bladder_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#2_top-relative-expression-ranked_500 | 1.88e-03 | 86 | 16 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | 1.90e-03 | 740 | 16 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.94e-03 | 744 | 16 | 4 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_500 | 2.10e-03 | 91 | 16 | 2 | gudmap_developingGonad_e14.5_ epididymis_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#1_top-relative-expression-ranked_500 | 2.10e-03 | 91 | 16 | 2 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_500 | 2.14e-03 | 92 | 16 | 2 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_500 | 2.23e-03 | 94 | 16 | 2 | gudmap_developingGonad_e18.5_testes_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 2.27e-03 | 776 | 16 | 4 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| CoexpressionAtlas | e10.5_Nasal_Pit_top-relative-expression-ranked_500 | 2.33e-03 | 362 | 16 | 3 | Facebase_ST1_e10.5_Nasal_Pit_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_100 | 2.38e-03 | 97 | 16 | 2 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 2.48e-03 | 795 | 16 | 4 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | 2.50e-03 | 797 | 16 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | 2.65e-03 | 810 | 16 | 4 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_1000 | 2.76e-03 | 819 | 16 | 4 | gudmap_developingGonad_P2_testes_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | 2.77e-03 | 820 | 16 | 4 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | 2.78e-03 | 385 | 16 | 3 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 2.86e-03 | 827 | 16 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.95e-03 | 834 | 16 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 2.99e-03 | 395 | 16 | 3 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.04e-03 | 110 | 16 | 2 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 3.25e-03 | 407 | 16 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1 | 3.30e-03 | 409 | 16 | 3 | GSM476663_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_500 | 3.36e-03 | 412 | 16 | 3 | gudmap_developingGonad_e18.5_testes_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 3.39e-03 | 413 | 16 | 3 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_500 | 3.43e-03 | 117 | 16 | 2 | gudmap_developingGonad_P2_testes_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500 | 3.58e-03 | 421 | 16 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500 | |
| CoexpressionAtlas | Stem Cells, SC.STSL.BM, CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Bone marrow, avg-3 | 3.62e-03 | 423 | 16 | 3 | GSM399454_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.79e-03 | 123 | 16 | 2 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 3.97e-03 | 437 | 16 | 3 | GSM777046_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.35e-03 | 132 | 16 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500 | 4.61e-03 | 136 | 16 | 2 | gudmap_developingGonad_P2_epididymis_500_k2 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.73e-07 | 188 | 17 | 4 | e239bcdbd210a398a5850cb6fbf171d402f45a4f | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.32e-07 | 192 | 17 | 4 | ceadfbce037bef15523916ba091bb6c0d752cce5 | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.32e-07 | 192 | 17 | 4 | f388a336062880609724e91bf51bd0f9c4da2f69 | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-07 | 193 | 17 | 4 | 733f557bdc80293b40ccdf560f1675793df932d6 | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-07 | 193 | 17 | 4 | eb3c46b6fb06dc8708dc3032189b47ed93ee2357 | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-07 | 193 | 17 | 4 | b45cd02081f97904eaea2d013e1fa980505d060b | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-07 | 194 | 17 | 4 | 0d2e65b44e3f143971c2fd24c4552f042b049cfa | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-07 | 194 | 17 | 4 | 9709dc95fb6982b6a0467b507845d5bc17252e3e | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-07 | 194 | 17 | 4 | 93b7a9065430740ec31fce4e8c14ffccb498591d | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.79e-07 | 195 | 17 | 4 | 773728703bc8969bff0e1de58fe3e1631add0a0a | |
| ToppCell | facs-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.28e-07 | 198 | 17 | 4 | e85ae846e293687fd193f4d565525d8d3bd1faea | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.68e-05 | 188 | 17 | 3 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.75e-05 | 189 | 17 | 3 | 8e6b6025f5554672e26a5d19fe365acb4333789c | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-05 | 190 | 17 | 3 | 3720e64129f3f3268b1dc14031a76f41c38241c2 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-05 | 190 | 17 | 3 | 73a50426f972f08f9bb525ad5c0b774187ab5d6a | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-05 | 190 | 17 | 3 | b55cf1fb586b724295b7b038483249847bb344fc | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 191 | 17 | 3 | 783e8c436de90623bb1bc4117270d60c8c8a9461 | |
| ToppCell | facs-Trachea-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.98e-05 | 192 | 17 | 3 | e8af6ad1ae99cae13a82d0d8d7f38af9b777f0ba | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.98e-05 | 192 | 17 | 3 | fc940f91ff8e051631dbf25e6e8d73cf8337eccb | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.98e-05 | 192 | 17 | 3 | 7a2e79490e4f7058bb76b46c45b5df9f729e3146 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-05 | 193 | 17 | 3 | 25248b8e65d558b1a96a87c93e3e5b4c0ba168fe | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-05 | 193 | 17 | 3 | f1f1097204e07a7bed416425b8256942038a734f | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-05 | 193 | 17 | 3 | eff718664fe0aaf89050efd9cc7b6dfb1df46666 | |
| ToppCell | facs-MAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 194 | 17 | 3 | f906b090f67df4cfe3498cdbb52cc0efa08e06cc | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.13e-05 | 194 | 17 | 3 | 8b81f039f5b25d35a4d5a41b27d4d9360ba22f15 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.13e-05 | 194 | 17 | 3 | af4bbb2deb5a3913eb58990690fc3c62fbc3708c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.13e-05 | 194 | 17 | 3 | 4e93bd903cddfd0c8f220b6a35b449895de4119b | |
| ToppCell | facs-MAT-Fat-18m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 194 | 17 | 3 | 944cdb0403d80a10a2eea2a3516a9343dbccc32c | |
| ToppCell | facs-MAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 194 | 17 | 3 | 85081d255fcc1e9854c0073321dd9f0feaa48866 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 194 | 17 | 3 | bc945450b350f597c3ff910d3a14a533d90086a8 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.13e-05 | 194 | 17 | 3 | 889c6e231bdd5b59902c7d2afdc077360b1d3256 | |
| ToppCell | facs-Trachea-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.21e-05 | 195 | 17 | 3 | 0d1876f6fdc1eafeb60d6fd7da5bce737d2b4a5a | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-05 | 195 | 17 | 3 | 5c05e2bcea3d5d7ebe6325f7187ccf83301053d8 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-05 | 195 | 17 | 3 | 690d6e15d7c863fc8f2d33b1f7bf86f019f415c9 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-41|World / Primary Cells by Cluster | 5.29e-05 | 196 | 17 | 3 | dee0984cd63a1a2fdebb4421af48ab566a5b684e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 5.29e-05 | 196 | 17 | 3 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 5.29e-05 | 196 | 17 | 3 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Airway_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.37e-05 | 197 | 17 | 3 | 233caeee200ca905900226f85426e084caf290fb | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.37e-05 | 197 | 17 | 3 | 47c4d9de71a435119c71f5219de836cf9b2aab6d | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.37e-05 | 197 | 17 | 3 | 3fe665c0277d091290b63f0dd24c0c6536a45309 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.45e-05 | 198 | 17 | 3 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.54e-05 | 199 | 17 | 3 | 6723287924750a2247a07ab6e561066a97b09771 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.54e-05 | 199 | 17 | 3 | 66545eb7f65e450b742628fd431956e13330a0d3 | |
| ToppCell | NS-critical-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.54e-05 | 199 | 17 | 3 | b88a81cd2a89f4d27100c96ae4324dcee68daf83 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.54e-05 | 199 | 17 | 3 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 5.54e-05 | 199 | 17 | 3 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.54e-05 | 199 | 17 | 3 | 8766796041965a1ba40ad7abdbc244bf1418c209 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.54e-05 | 199 | 17 | 3 | 49690494270981eec5b5261c59e0545dff90cc21 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.54e-05 | 199 | 17 | 3 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | NS-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.54e-05 | 199 | 17 | 3 | d64adb68502be596ce55fb2cb63fe1cfa2c5f8ba | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.54e-05 | 199 | 17 | 3 | 5a425e7d11c5911ff5855c27a7f058a7ed7abbb0 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.54e-05 | 199 | 17 | 3 | 67f78c070c56e44fba36542041bf7fa1c291807c | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.54e-05 | 199 | 17 | 3 | 1ae244b563f85c1ee8d22698f478c842a4d9c7f5 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.54e-05 | 199 | 17 | 3 | d39b40d84c72bdde756b805063317ecfad3784f8 | |
| ToppCell | 10x_3'_v2v3-Neoplastic|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.62e-05 | 200 | 17 | 3 | e9c7d7cb5fa63fc92aa91d02ae8bd05438d465bc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Neuron|2m / Sample Type, Dataset, Time_group, and Cell type. | 5.62e-05 | 200 | 17 | 3 | a581f1704a87b0390e1e2ff85053367d85247755 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 5.62e-05 | 200 | 17 | 3 | 8795920911ee75c09a97cc948c14ad7301b27796 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-OPC_related-Oligodendrocyte/OPC|2m / Sample Type, Dataset, Time_group, and Cell type. | 5.62e-05 | 200 | 17 | 3 | 3c9a2f02294a9fb892b89e856291bd6423ffa0a9 | |
| ToppCell | control-Lymphoid-NKT-proliferating|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.62e-05 | 200 | 17 | 3 | f8b5e5464b2ffef7b0ce75f60839c8ef791e17ba | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Cortical_neuron|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 5.62e-05 | 200 | 17 | 3 | 7bba2ff09349c8db3d1ccf53520b12cbf7b0abac | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-OPC_related|2m / Sample Type, Dataset, Time_group, and Cell type. | 5.62e-05 | 200 | 17 | 3 | 8e49e7e9b02d8411e4ffae1f5113a2c18f5bf179 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 5.62e-05 | 200 | 17 | 3 | fd6b4ff4330db11c03f1eb4e06b43a162326f744 | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.62e-05 | 200 | 17 | 3 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | metastatic_Lymph_Node-Epithelial_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.62e-05 | 200 | 17 | 3 | 07408011b37d32a20164866cf5da9dd120985357 | |
| ToppCell | Lung_Parenchyma|World / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.70e-05 | 201 | 17 | 3 | 91ec5eebe93a3c7b1a33c27e5da949b123b676a8 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-Neuronal-Neurons|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.76e-04 | 65 | 17 | 2 | 3c094b098edc216b0bb23a5cbce7950e27713782 | |
| ToppCell | VE-CD4-CD8_2|VE / Condition, Cell_class and T cell subcluster | 9.66e-04 | 122 | 17 | 2 | 6745035feaf807b6a6b9537ac9d5ee0e000196eb | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-Neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.20e-03 | 136 | 17 | 2 | b46450292e0cd549eb3bafdd3fed22f41d85bfbe | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.23e-03 | 138 | 17 | 2 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.30e-03 | 142 | 17 | 2 | f720f13b339589fa924a42e89393e5db0b26300b | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 1.49e-03 | 152 | 17 | 2 | f944743f40ff6ed3a7a096dd53e12d3526c67c4d | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-03 | 154 | 17 | 2 | dd3d34f065820e706515a13619f19a5b12734c8e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-03 | 154 | 17 | 2 | 4bfda1c41efbb86d829b3797d1168bf2587c3c97 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.63e-03 | 159 | 17 | 2 | fb9a45c1d596226128ce4f1adaebb066766e590a | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|Lung / Manually curated celltypes from each tissue | 1.65e-03 | 160 | 17 | 2 | 9f7f24a52a24fb926df69c8e5aad64ee75a66ef1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.67e-03 | 161 | 17 | 2 | bd520c9a1927d5d5355b4421e6b90b58bfb76a42 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.69e-03 | 162 | 17 | 2 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.69e-03 | 162 | 17 | 2 | 58da6bc04cdac0002b0e6a751c96ff95e1a7f70f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.69e-03 | 162 | 17 | 2 | 4d13c271b4f63cf32980e5643b5d5951165fe8b5 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.69e-03 | 162 | 17 | 2 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.71e-03 | 163 | 17 | 2 | bba830a302919c8b33f914a8839877fc21dd28a0 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.73e-03 | 164 | 17 | 2 | 08819970174a3eb4eee8e1e675075828665b845e | |
| ToppCell | Basal-basal-4|World / Class top | 1.77e-03 | 166 | 17 | 2 | 2721772eb2a9f45c5e9aaf4d73d198fea11a3586 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.84e-03 | 169 | 17 | 2 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-03 | 170 | 17 | 2 | 36c9f7f98612a72dc511c8da4358d67444f6bcf4 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-03 | 170 | 17 | 2 | 4cd3b7e43a061948084c01713ae141b5c2c07d89 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.95e-03 | 174 | 17 | 2 | 7d4b860e05b5931f6f9d757a68f75ff35597a47a | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-03 | 174 | 17 | 2 | 9d22a554617a93701d0945de63cc3e7b24322c40 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 175 | 17 | 2 | 8902c38067f025b094ca9c28c449c32a66eded1c | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 175 | 17 | 2 | 6bb8fc2959583644f16b22e906af91af62a3a633 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 175 | 17 | 2 | f1166b567bca80dac3abe90c3dc544c831006640 | |
| ToppCell | severe_influenza-Plasmablast|World / disease group, cell group and cell class (v2) | 1.97e-03 | 175 | 17 | 2 | e6d6c44510d5dc4eb0bae820125e42366f7a4e74 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.99e-03 | 176 | 17 | 2 | a31d7532f8c055d4e62bbaa78d819f2495bfee00 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.99e-03 | 176 | 17 | 2 | 0710689e66deba179b0a8038cdd56b4834984f12 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.99e-03 | 176 | 17 | 2 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-03 | 177 | 17 | 2 | 921783ed0fe20294d2f384d9136924b679df01bb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-03 | 178 | 17 | 2 | 6f61490d79cd1727ed2d5cc673823dd4efdafac1 | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland|Trachea / Age, Tissue, Lineage and Cell class | 2.04e-03 | 178 | 17 | 2 | 3e406e38eea0d38dc25edecf703c4c89ec6a28e0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-03 | 178 | 17 | 2 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-03 | 179 | 17 | 2 | 8001db3044e8657980e24422377c4fdb0d7b323e | |
| Drug | 7-biopterin | 1.16e-10 | 13 | 16 | 4 | CID005488923 | |
| Drug | 3-bp | 6.26e-10 | 19 | 16 | 4 | CID005326878 | |
| Drug | pantothenoyl-aminoethenethiol | 1.25e-09 | 73 | 16 | 5 | CID000447227 | |
| Drug | NSC325316 | 1.43e-09 | 23 | 16 | 4 | CID000331608 | |
| Drug | 4alpha-hydroxytetrahydrobiopterin | 2.04e-09 | 25 | 16 | 4 | CID000129803 | |
| Drug | A-K-V | 1.06e-08 | 37 | 16 | 4 | CID011840919 | |
| Drug | 2,6-dihydroxybenzoic acid | 1.03e-07 | 175 | 16 | 5 | CID000009338 | |
| Drug | itraconazole oral solution | 6.37e-07 | 101 | 16 | 4 | CID000003793 | |
| Drug | ST013873 | 1.70e-06 | 129 | 16 | 4 | CID000000624 | |
| Drug | pentifylline | 9.70e-06 | 7 | 16 | 2 | CID000070569 | |
| Drug | adenine | 1.97e-05 | 510 | 16 | 5 | CID000000190 | |
| Drug | 7-BH4 | 3.04e-05 | 12 | 16 | 2 | CID000126227 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.88e-04 | 163 | 16 | 3 | 5594_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.95e-04 | 165 | 16 | 3 | 5625_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 2.02e-04 | 167 | 16 | 3 | 5217_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.02e-04 | 167 | 16 | 3 | 3979_DN | |
| Drug | S-2-pentyl-4-pentynoic hydroxamic acid | 2.03e-04 | 834 | 16 | 5 | ctd:C513635 | |
| Drug | Chloroprene | 2.04e-04 | 1348 | 16 | 6 | ctd:D002737 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.06e-04 | 168 | 16 | 3 | 6820_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.10e-04 | 169 | 16 | 3 | 5231_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.17e-04 | 171 | 16 | 3 | 6879_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.17e-04 | 171 | 16 | 3 | 4954_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.21e-04 | 172 | 16 | 3 | 6993_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.21e-04 | 172 | 16 | 3 | 7179_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.21e-04 | 172 | 16 | 3 | 3428_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.21e-04 | 172 | 16 | 3 | 4112_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.28e-04 | 174 | 16 | 3 | 5945_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.40e-04 | 177 | 16 | 3 | 6434_DN | |
| Drug | A-Mate | 2.41e-04 | 33 | 16 | 2 | CID000010944 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.44e-04 | 178 | 16 | 3 | 992_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.44e-04 | 178 | 16 | 3 | 1471_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.44e-04 | 178 | 16 | 3 | 1112_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.44e-04 | 178 | 16 | 3 | 6276_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A | 2.48e-04 | 179 | 16 | 3 | 332_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.56e-04 | 181 | 16 | 3 | 7005_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 3.00e-04 | 191 | 16 | 3 | 4283_DN | |
| Drug | testosterone glucuronide | 3.74e-04 | 41 | 16 | 2 | CID000108192 | |
| Drug | C8-ceramide | 5.07e-04 | 556 | 16 | 4 | CID000002508 | |
| Disease | Intellectual Disability | 8.19e-05 | 447 | 16 | 4 | C3714756 | |
| Disease | cognitive function measurement | 7.50e-04 | 1434 | 16 | 5 | EFO_0008354 | |
| Disease | platelet crit | 1.44e-03 | 952 | 16 | 4 | EFO_0007985 | |
| Disease | Global developmental delay | 2.32e-03 | 133 | 16 | 2 | C0557874 | |
| Disease | bipolar disorder | 3.45e-03 | 577 | 16 | 3 | MONDO_0004985 | |
| Disease | monocyte count | 4.71e-03 | 1320 | 16 | 4 | EFO_0005091 | |
| Disease | Abnormality of refraction | 5.30e-03 | 673 | 16 | 3 | HP_0000539 | |
| Disease | Alzheimer disease, educational attainment | 7.75e-03 | 247 | 16 | 2 | EFO_0011015, MONDO_0004975 | |
| Disease | pyruvate measurement | 9.07e-03 | 268 | 16 | 2 | EFO_0010117 | |
| Disease | QRS duration | 1.11e-02 | 298 | 16 | 2 | EFO_0005055 | |
| Disease | household income | 1.15e-02 | 304 | 16 | 2 | EFO_0009695 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SYDKMKRQKRKRKKK | 1261 | Q9NR48 | |
| RKHVRKNYMKFKAKF | 1046 | Q9UKL3 | |
| RKRKYFKKHEKRMSK | 36 | Q12857 | |
| ARKRKYFKKHEKRMS | 36 | O00712 | |
| RKRKYFKKHEKRMSK | 36 | Q14938 | |
| HELKKFRKMFYVKKD | 271 | O00180 | |
| RERRKKKYQKRMKIK | 576 | O00566 | |
| RIEKQTKHMKKYPKR | 686 | A2RUB6 | |
| LKKASKRMTCHKRYK | 6 | Q9BVP2 | |
| RKKKQHRFKYKMKGK | 2181 | Q8NDH2 | |
| RRKKKSSKRKHKKYS | 196 | Q8N5F7 | |
| KMKKDYRKKYRKYVR | 131 | Q96P20 | |
| CKTRKKYNKEMSKRK | 151 | Q7Z5D8 | |
| ARKRKYFKKHEKRMS | 36 | P08651 | |
| KSEKAYRKSRKKHKK | 41 | P61129 | |
| YRKSRKKHKKEREKK | 46 | P61129 | |
| KHFSSKRKYDKRRKK | 1061 | Q9BXT5 | |
| KSYRKKSVEMKHRKV | 191 | Q96ND8 |